Latest News about NVS
Recent news which mentions NVS
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
From InvestorPlace
Molecular Partners Says Its COVID-19 Antiviral Still Effective Against Positions Mutated In Omicron
November 30, 2021
From Benzinga
3 Pharma Stocks That Are Too Cheap to Ignore
November 25, 2021
From Motley Fool
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
From Benzinga
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
November 23, 2021
From Motley Fool
1 Cancer Stock on Buyout Watch in 2022
November 21, 2021
From Motley Fool
From Benzinga
See Why Molecular Partners Shares Dropped To 52-Week Low During Tuesday Premarket?
November 16, 2021
From Benzinga
This Company's Innovative Targeted Radiation Therapy Could Offer Potential Hope for Cancer Patients
November 11, 2021
From Benzinga
Novartis Dumps Another Bispecific Candidate From Xencor Deal
November 09, 2021
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
64 Stocks Moving In Friday's Mid-Day Session
November 05, 2021
From Benzinga
From Benzinga
Why Did Deciphera Stock Plunged 70% Today?
November 05, 2021
From Benzinga
Europe stocks head for a fresh record close, led by Roche and oil giants
November 04, 2021
From MarketWatch
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
Novartis To Offload Its Stake Back To Roche For $20.7B
November 04, 2021
From Benzinga
Novartis Inks $1.3B Protein Degradation Deal With UK's Dunad
November 02, 2021
Tickers
NVS
From Benzinga
FDA Approves Novartis' Scemblix In Two Chronic Myeloid Leukemia Settings
November 01, 2021
From Benzinga
Europe stocks off highs as Deutsche Bank slides after results
October 27, 2021
From MarketWatch
Should Biogen Investors Be Preparing for the Worst?
October 27, 2021
From Motley Fool
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
From Benzinga
Novartis Mulls Strategic Options For Sandoz, Reaffirms FY21 Outlook
October 26, 2021
Tickers
NVS
From Benzinga
Earnings Scheduled For October 26, 2021
October 26, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.